Search Within

William D Travis

Formats
  1. Journal Article (359)
  2. Meeting Abstract (286)
  3. Book Section (60)
  4. Review (20)
  5. Guidelines (9)
  6. Editorial (8)
  7. Correspondence (6)
  8. Book Whole (3)
Groups
  1. Department of Pathology and Laboratory Medicine (751)
  2. Surgery (281)
  3. Department of Medicine (210)
  4. Solid Tumor Oncology Division (195)
  5. Thoracic Oncology (186)
  6. GSK Faculty (160)

More Groups

People
  1. Natasha Rekhtman (193)
  2. Prasad Adusumilli (156)
  3. Valerie Rusch (144)
  4. Marc Ladanyi (94)
  5. Jennifer Sauter (75)
  6. Kyuichi Kadota (73)

More People

Years
  1. 2025 (19)
  2. 2024 (20)
  3. 2023 (19)
  4. 2022 (34)
  5. 2021 (38)
  6. 2020 (38)

More Years

Publications
  1. Journal of Thoracic Oncology (182)
  2. Modern Pathology (109)
  3. Laboratory Investigation (95)
  4. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (44)
  5. Journal of Clinical Oncology (22)
  6. American Journal of Surgical Pathology (21)

More Publications

Publishers
  1. Elsevier Inc. (207)
  2. Nature Research (109)
  3. Nature Publishing Group (106)
  4. International Agency for Research on Cancer (44)
  5. Lippincott Williams & Wilkins (26)
  6. American Association for Cancer Research (23)

More Publishers

Results (751)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New pathologic classification of lung cancer: Relevance for clinical practice and clinical trials
    Journal Article

    Travis, W. D.; Brambilla, E.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma
    Journal Article

    Rekhtman, N.; Tafe, L. J.; Chaft, J. E.; Wang, L.; Arcila, M. E.; Colanta, A.; Moreira, A. L.; Zakowski, M. F.; Travis, W. D.; Sima, C. S.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • WHO histologic classification is an independent predictor of prognosis in lung neuroendocrine (NE) tumors but Ki-67 proliferation rate is not
    Meeting Abstract

    Wang, H.; Iyoda, A.; Roh, M. S.; Sica, G.; Rekhtman, N.; Pietanza, M. C.; Sarkaria, I.; Travis, W. D.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • WHO histologic classification is an independent predictor of prognosis in lung neuroendocrine (NE) tumors but Ki-67 proliferation rate is not
    Meeting Abstract

    Wang, H.; Iyoda, A.; Roh, M. S.; Sica, G.; Rekhtman, N.; Pietanza, M. C.; Sarkaria, I.; Travis, W. D.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Fatty acid hydrolase is preferentially expressed in pulmonary carcinoid tumors
    Meeting Abstract

    Shilo, K.; Ravi, J.; Nasser, M.; Cohen, D.; Zhao, W.; Villalona, M.; Fukuoka, J.; Jen, J.; Franks, T.; Travis, W.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Fatty acid hydrolase is preferentially expressed in pulmonary carcinoid tumors
    Meeting Abstract

    Shilo, K.; Ravi, J.; Nasser, M.; Cohen, D.; Zhao, W.; Fukuoka, J.; Jen, J.; Franks, T.; Travis, W.; Ganju, R.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Napsin A expression in neuroendocrine tumors of the lung
    Meeting Abstract

    Joubert, P.; Wang, H.; Roh, M. S.; Pietanza, M. C.; Sarkaria, I.; Travis, W. D.; Rekhtman, N.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Napsin A expression in neuroendocrine tumors of the lung
    Meeting Abstract

    Joubert, P.; Wang, H.; Roh, M. S.; Pietanza, M. C.; Sarkaria, I.; Travis, W. D.; Rekhtman, N.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • American Cancer Society lung cancer screening guidelines
    Journal Article

    Wender, R.; Fontham, E. T. H.; Barrera, E. Jr; Colditz, G. A.; Church, T. R.; Ettinger, D. S.; Etzioni, R.; Flowers, C. R.; Gazelle, G. S.; Kelsey, D. K.; more...
    CA - A Cancer Journal for Clinicians (2013)

    Fulltext@MSK | Save
  • Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence
    Journal Article

    Suzuki, K.; Kadota, K.; Sima, C. S.; Nitadori, J.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save